Curiously, a p53 mutant that cannot be acetylated on certain lysine residues (3KR mutant) loses its ability to induce cell cycle arrest, senescence, or apoptosis, yet is still capable of suppressing tumor formation in vivo (Li et al., 2012). Here, TP53 is linked to neoplasm.